Medical University Graz, Department of Plastic, Aesthetic and Reconstructive Surgery Graz
Graz, Styria, 8036, Austria
NCT Number: NCT04587570
Rhizarthrosis is the wear of the thumb saddle joint. It is a very common disease affecting up to 25% of postmenopausal women. There are currently various conservative and surgical methods available for treatment. If conservative treatment does not lead to freedom from pain, one of the surgical methods can be used, such as metacarpal extension osteotomy, trapeziectomy with or without ligamentoplasty, trapeziometacarpal arthrodesis, prosthesis implantation and various forms of interposition arthroplasty . Despite the high satisfaction rate of up to 95% after surgical treatment, the anatomy of the carpus is irreversibly destroyed . Apart from that, these operations are also associated with corresponding complications and post-operative immobilization of several weeks. Thus, a minimally invasive treatment method with a corresponding success rate would be of great advantage.
Hypothesis:
By infiltrating and filling the joint with Platelet-Rich Plasma (PRP), fat or a combination of both, the pain of rhizarthrosis can be reduced.
Aim of the study:
The aim of the announced doctoral thesis is to investigate the effect of PRP, lipofilling and its combination on arthroses of the thumb saddle joint after a single joint injection and to compare it with a control group.It is to be proven that PRP, fat and their combination lead to a different degree of pain relief compared to the control group due to the expansion of the joint space and the associated filling effect.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Graz, Styria, 8036, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Infiltration with 1.5 ml PRP
Infiltration with 1.5 ml Fat
Infiltration with 0.75 ml PRP and 0.75 ml Fat
Infiltration with 1.5 ml NaCl
Time frame: is measured 5 times, from screening visit to 3 months after intervention
assessed by VAS (Visual Analogue scale). The range goes from 0 (no pain) to 10 (worst imaginable pain).
Time frame: is measured 5 times, from screening visit to 3 months after intervention.
Evaluated by dynamometer: tweezergrip with Pinch-Gauge-Dynamometer, Crossgrip with Jamar-Dynamometer
Time frame: is measured 5 times, from screening visit to 3 months after intervention.
assessed by Kapandji-score, measured degrees of motion Dig I MCP, Dig I IP. A score of 0 indicates no opposition, a score of 10 indicates maximal opposition.
Time frame: is measured 5 times, from screening visit to 3 months after intervention.
The SF36 consists of 8 domains, the range of every scale goes from 0-100. A higher score indicates no restriction in health. 0 =greatest possible restriction of health; 100 = absence of health restrictions
Time frame: is measured 5 times, from screening visit to 3 months after intervention.
Upper-extremity disability and symptoms are assessed by the DASH-Score. The range goes from 0 (no disability) to 100.
Time frame: is measured 5 times, from screening visit to 3 months after intervention.
The MHQ has six domains. Overall hand function, activities of daily living (ADLs), work performance, aesthetics, and patient satisfaction) are scored from 0 - 100 in which 100 is the best possible ability.
The pain domain is scored from 0 - 100, where 0 indicates no pain.
Time frame: is measured 5 times, from screening visit to 3 months after intervention.
lateralgrip of dump and index finger
Medical University of Graz
Other
Injection of Platelet Rich Plasma and Autologous Fat Into the Thumb Carpometacarpal Joint for the Evaluation Their Potential Filling Effect in Patients With Osteoarthritis
Acronym: RHI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05915962
Rhizarthrosis
Champigny-sur-Marne, France
View Trial DetailsNCT03431584
Rhizarthrosis
Cholet, France
View Trial DetailsNCT06858800
Arthritis, Joint Diseases
Barcelona, Spain
View Trial DetailsNCT03879434
Rhizarthrosis
Berlin, State of Berlin, Germany
View Trial Details